PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,438,509 | -20.0% | 148,644 | -2.8% | 0.10% | -9.7% |
| Q2 2023 | $5,544,981 | -13.7% | 152,965 | -2.9% | 0.11% | -13.7% |
| Q1 2023 | $6,428,105 | +12.1% | 157,513 | +6.0% | 0.13% | +12.0% |
| Q4 2022 | $5,734,666 | -28.6% | 148,528 | -1.6% | 0.12% | -29.9% |
| Q3 2022 | $8,032,000 | -5.0% | 150,997 | +4.2% | 0.17% | 0.0% |
| Q2 2022 | $8,452,000 | -15.2% | 144,976 | +11.0% | 0.17% | +5.0% |
| Q1 2022 | $9,968,000 | +26.7% | 130,612 | -0.1% | 0.16% | +39.5% |
| Q4 2021 | $7,869,000 | +5.1% | 130,785 | -2.2% | 0.11% | +1.8% |
| Q3 2021 | $7,489,000 | -6.0% | 133,736 | +1.9% | 0.11% | -5.1% |
| Q2 2021 | $7,963,000 | -1.0% | 131,222 | +14.4% | 0.12% | -2.5% |
| Q1 2021 | $8,042,000 | – | 114,734 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |